12 Nov 2020 07:00
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 10 November 2020, the PDMR listed below was granted options over ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017 at a nil exercise price:
Name of PDMR | Number of shares subject to option |
Richard Jones | 443,077 |
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation and set out more details of the transactions.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||
a)
| Name | Mr Richard Jones | |||
2
| Reason for the notification
| ||||
a)
| Position/status
| Chief Financial Officer | |||
b)
| Initial notification /Amendment
| Initial notification in each case | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||
a)
| Name
| Medica Group PLC | |||
b)
| LEI
| 213800B8XE5FUSZF5Z16 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 0.2p each in the capital of the Company ("Shares") | |||
b)
| Nature of the transaction
| Grant of options to acquire Shares pursuant to the Company's Performance Share Plan 2017 | |||
c)
| Price(s) and volume(s) | Exercise Price nil | |||
d)
| Aggregated information | N/A | |||
e)
| Date of the transaction
| 10 November 2020 | |||
f)
| Place of the transaction
| Outside a trading venue | |||